Since 2021, China National Medical Products Administration (NMPA) released and implemented the Cosmetic Supervision and Administration Regulation and a series of subsidiary regulations, reconstructing the entire cosmetics regulatory system. The regulatory focus of NMPA is gradually shifting from the previous emphasis on pre-market approval to the combination of pre-market approval and post-market surveillance.
China's brand-new regulatory system has similarities and differences with the EU's. For European companies or companies already marketing cosmetics in Europe, what differences should be considered before placing cosmetics on the Chinese market? In this webinar, Hedy He from ChemLinked will detail the similarities and differences in basic regulatory information, pre-market requirements, post-market surveillance, company responsibility, etc.
Notes:
Please feel free to send us questions before the webinar;
The presentation deck and recording video will be uploaded to this webpage after the webinar;
If you can't attend the live webinar, register anyway and we will send you the webinar materials as soon as they’re available.
